Evoke Pharma, Inc. (NASDAQ: EVOK) announced positive guidance from a recent second pre-NDA (New Drug Application) meeting to discuss clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE